Previous
Pause
Next
Skip to Navigation
↓
Congresses
Year
Year
Year
-Year
1980
1981
1982
1983
1984
1985
1986
1987
1988
1989
1990
1991
1992
1993
1994
1995
1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
Researcher
- Any -
claramalo
usuario_prueba
Almeida e Silva, Filomena Augusta
Arenal , Raúl
Baptista , Pedro Miguel
Bernechea Navarro, María
Bover Arbós, Pere
Calvo Lacosta, Jorge Hugo
Carstensen , Hans-Heinrich
Castro Barrigón, Alberto
Cazcarro Castellano, Ignacio
Cobarrubias Baglietto, Sebastián Felipe
DeMiguel , Daniel
Domínguez Castro, Fernando
Ferrio Díaz, Juan Pedro
Gil Hernández, Vanesa
Gil Mestres, Adriá
Gracia Lostao, Ana Isabel
Gurauskis , Jonas
Hernández Ainsa, Silvia
Hernández Latas, José Antonio
Hurtado Guerrero, Ramón
Jiménez Schuhmacher, Alberto
Juarez-Perez , Emilio J.
Knoll , Fabien
Köhler , Ralf
Lopes de Sousa Martins, Pedro Alexandre
Mangas-Sánchez , Juan
Martínez Pérez, María
Martínez-Padilla , Jesús
Millán Gasca, Javier
Montiel , Manuel
Muñoz Soro, José Félix
Olmo , Jose
Ordovás Vidal, Laura
Pardo Jimeno, Julián
Pey Betrán, Jorge
Philippidis , George
Ramón García, Santiago
Roque , Carla
Sanz Pamplona, Rebeca
Schoorlemmer , Jon
Sola , Daniel
Stavridis , Stelios
del Río , María Pilar
Íñiguez Dieste, David
Title
Title
Year
Potencial terapéutico de las células NK humanas en el tratamiento de neoplasias hematológicas resistentes a protocolos clásicos de quimioterapia
2011
La union a liposomas aumenta dramaticamente la efectividad de Apo2L/TRAIL contra tumores hematologicos.
2011
Las células NK humanas son capaces de eliminar células tumorales resistentes a tratamientos clásicos de quimioterapia
2011
Fast and sensitive detection of the mycotoxin gliotoxin and related compounds during human aspergillosis
2011
A novel HPTLC analytical method for quantification and separation of mycotoxin gliotoxin and related compounds in human samples.
2011
Microgranuloma Formation Is Not Enough for Control and Survival Following Infection With the Novel Murine Pathogen Brucella microti
2011
Pleiotropism of granzyme B-induced cell death; A means of the host to counter pathogen (tumor) evasion strategies of Tc cell-mediated recovery
2010
Course of infection in immunodeficient mice experimentally inoculated with the emerging mouse pathogen Brucella microti
2010
In vitro-expanded and ex vivo-derived human NK cells as a tool to study cell death induced by cytotoxic cells on hematologic neoplasias
2010
Mitochondrial DNA depletion sensitizes L929 cells to death receptor-mediated cell death
2010
Multiple pathways of granzyme B-induced cell death: result of evolutionary pressure from pathogens (tumors) to evade cytotoxic cells.
2010
Caspase-dependent inhibition of mousepox (ectromelia) replication by gzmB
2009
Cell death induced on macrophages by mycobacterium tuberculosis or attenuated strain so2
2009
Apoptosis induction in ectromelia (mouse pox) infected target cells is modulated by one or more gzmb-mediated pathways
2009
: granzyme a and b of mouse cytotoxic t cells cleave cytoplasmic and plasma gelsolin: consequences for cell morphology inflammatory responses
2009
Caspase-dependent inhibition of mousepox (ectromelia) replication by gzmB
2009
Granzyme A activates a pro-inflammatory cytokine response in macrophages
2009
Role of granzyme B in the cytotoxic T cell attack against the natural mouse pathogen, ectromelia virus
2008
GzmB of ex vivo CTLs induces NADPH oxidase-mediated reactive oxygen species via activation of caspases and independent of mitochondria
2008
Acid sphingomyelinase is a critical regulator of cytotoxic granule secretion by primary T lymphocytes
2008
Pages
« primera
‹ anterior
1
2
3
4
5
siguiente ›
última »